MétaCan
Menu
← Back to cohort
Record W276549403 · doi:10.5114/aoms.2011.26602

Editorials Statins: the high risks of discontinuation and large benefits of continuation

2011· article· en· W276549403 on OpenAlexfundno aff
Charles H. Hennekens, Joanna Drowos

Bibliographic record

VenueArchives of Medical Science · 2011
Typearticle
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsnot available
FundersNational Institutes of HealthCanadian Institutes of Health ResearchUniversidad del AtlánticoInternational Atherosclerosis SocietySunovionBrigham and Women's HospitalBristol-Myers SquibbFlorida Atlantic UniversityGlaxoSmithKlineStrykerAmgen
KeywordsMedicineDiscontinuationStatinStroke (engine)Randomized controlled trialMyocardial infarctionAtherosclerotic cardiovascular diseaseInternal medicineCholesterolRelative riskRevascularizationCardiologyDiseaseConfidence interval

Abstract

fetched live from OpenAlex

In their mini-review/short communication in this issue of the Archives of Medical Science, Dr. Paraskevas et al. [1] draw proper attention to the consequences of statin discontinuation.They focus primarily on the cerebrovascular disease but their conclusion that absolute benefits of discontinuation are small and the absolute risks are high is consistent with a large and robust totality of evidence.The Cholesterol Treatment Trialist's Collaboration [2, 3] published two worldwide and comprehensive meta-analyses of randomized data.The first, among about 90,000 participants in 14 randomized trials, showed that statin therapy produced statistically significant and clinically important reductions in myocardial infarction, stroke, cardiovascular death and total mortality and a remarkable safety profile.The second, among 170,000 participants in 26 randomized trials, showed that further reductions by statins in low density lipoprotein (LDL) cholesterol safely produce definite further reductions in the incidence of myocardial infarction, stroke and revascularization.Specifically, each 1.0 mmol/l reduction in LDL cholesterol produces a statistically significant and clinically important reduction in the annual rate of these major vascular events by just over 20%.There was no evidence of any threshold within the cholesterol range studied, suggesting that reduction of LDL cholesterol by 2-3 mmol/l would reduce risk by about 40-50%.Thus, the recent randomized trials of statins using higher doses against lower doses as the active comparator arm have contributed importantly relevant information to two long standing hypotheses [4].The first is that lower is better and the prior totality of evidence included basic research and observational epidemiological studies, including in rural China where the average total cholesterol is less than 3.7 mmol/l and those with total cholesterol levels that are 10% lower had significantly decreased risks of occlusive vascular events [5].The second is that there is no threshold and the meta analysis of the data from randomized trials with active comparators in secondary prevention contribute importantly relevant data to this hypothesis.In terms of primary prevention the JUPITER trial also contributes the most importantly relevant data as the randomized population had no prior events and a 10 year risk of a first CHD event of 16-18% [6].Further, at baseline the LDL was about 3.0 and subjects assigned to 20 mg rosuvastatin achieved a greater than

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.052
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: Editorial
Teacher disagreement score0.010
Threshold uncertainty score0.052

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.052
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0040.002
Science and technology studies0.0020.002
Scholarly communication0.0050.003
Open science0.0040.001
Research integrity0.0100.013
Insufficient payload (model declined to judge)0.0080.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.055
GPT teacher head0.334
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueArchives of Medical Science→Same topicLipoproteins and Cardiovascular Health→French-language works237,207→